Cipla inks investment pact with FIL Capital Investment
No financial deals of the agreement were disclosed
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck plans to sell its allergy business unit to cut debt
The sale, which could fetch about $636.42 million, is an attempt by the company to offload its debt after the Sigma Aldrich Corp…
TAKE Solutions names Raman Kapur as Independent Director
US-based Raman Kapur brings pharma and generics expertise to TAKE board
TAKE Solutions announced the appointment of a new…
Sales rep files sexual harassment claims against DRL, Promius Pharma
The case was filed on July 31, 2015 and the nature of the suit is civil rights-employment
A woman sales representative from…
US FDA warns of serious data integrity violations at DRL
The US Food and Drug Administration has warned DRL over serious data integrity violations, placing all its new applications or…
Romaco Group acquires Medipac
Romaco Group’s decision to purchase the assets of Medipac will strengthen its position in the effervescents sector
Romaco Group…
DRL welcomes govt’s move on simplifying taxation laws
The company, however, wants deferment of sunset clause for SEZs
Dr Reddy's Laboratories (DRL) has welcomed the government's…
Express Pharma (Vol.11, No.3) December 1-15, 2015
India's Foremost Pharma & Biotech Magazine
Delhi HC tells govt not to take coercive steps against pharma cos
Petitions were filed by pharma companies and an association of medicine manufacturing firms challenging the government's new drug…
Pfizer, IIT Delhi launch ‘Innovation & IP Program’
The programme will help to create healthcare innovations in India
Pfizer with IIT Delhi have announced the launch of ‘The Pfizer…